DUBLIN--(
BUSINESS WIRE
)--The
"Hepatitis B Vaccines: Global Strategic Business Report"
report has been added to
ResearchAndMarkets.com's
offering.
Global Hepatitis B Vaccines Market to Reach $3.4 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Hepatitis B Vaccines estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$3.4 Billion by 2027, growing at a CAGR of 3.9% over the analysis period 2020-2027. Combination Vaccines, one of the segments analyzed in the report, is projected to record 4.4% CAGR and reach US$2.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Mono Vaccines segment is readjusted to a revised 3.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $715.6 Million, While China is Forecast to Grow at 6.5% CAGR
The Hepatitis B Vaccines market in the U.S. is estimated at US$715.6 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$668.6 Million by the year 2027 trailing a CAGR of 6.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.1% and 3.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.
Select Competitors (Total 14 Featured) -
Beijing Minhai Biotechnology Co., Ltd.
Bharat Biotech International Ltd.
Binnopharm Group LLC
Biokangtai
CSL Ltd.
Dynavax Technologies Corporation
Emergent BioSolutions, Inc.
GlaxoSmithKline PLC
Hualan Biological Engineering Co., Ltd.
Merck & Co., Inc.
What's New for 2022?
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Hepatitis B Vaccines - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
Companies Mentioned
Beijing Minhai Biotechnology Co., Ltd.
Bharat Biotech International Ltd.
Binnopharm Group LLC
Biokangtai
CSL Ltd.
Dynavax Technologies Corporation
Emergent BioSolutions, Inc.
GlaxoSmithKline PLC
Hualan Biological Engineering Co., Ltd.
Merck & Co., Inc.
For more information about this report visit
https://www.researchandmarkets.com/r/oixc6p